Report on Germany funded and developed COVID-19 tests provides ample evidence that millions were intentionally misdiagnosed for financial gain

Published on: December 9, 2022

The tests the WHO used and still uses today to claim millions were infected with and/or died of COVID-19 were designed, developed and distributed worldwide without having SARS-CoV-2 virus isolates or original patient specimens.

The COVID-19 tests that were/are used worldwide to diagnose COVID-19 infection don’t detect the SARS-CoV-2 itself.

Government of Canada website:

COVID-19 “tests do not detect the virus itself. Instead, they detect the antibodies produced in response to an infection. Serology tests are also known as antibody tests.”

“Serological tests are not appropriate for diagnosing COVID-19.”

Yet, the WHO, Justin Trudeau‘s minority government and governments worldwide used and are still using those bogus tests to test for/diagnose COVID-19 infection. Because those tests don’t detect SARS-CoV-2 millions were intentionally misdiagnosed so that Germany and the insolvent UN could obtain $billions.

Germany funded COVID-19 test developers stated in a January 2020 published report why the tests don’t detect SARS-CoV-2 and why millions were intentionally misdiagnosed as testing positive for COVID-19.

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

published on 23 Jan 2020

Background: The ongoing outbreak of the recently emerged novel coronavirus (2019-nCoV) poses a challenge for public health laboratories as VIRUS ISOLATES ARE UNAVAILABLE while there is growing evidence that the outbreak is more widespread than initially thought, and international spread through travellers does already occur.

Aim: We aimed to develop and deploy robust diagnostic methodology for use in public health laboratory settings WITHOUT HAVING VIRUS MATERIAL AVAILABLE.

Methods: Here we present a validated diagnostic workflow for 2019-nCoV, its design relying on close genetic relatedness of 2019-nCoV with SARS coronavirus, making use of synthetic nucleic acid technology.

“In the present case of 2019-nCoV, virus isolates or samples from infected patients have so far not become available to the international public health community. We report here on the establishment and validation of a diagnostic workflow for 2019-nCoV screening and specific confirmation, designed in absence of available virus isolates or original patient specimens. Design and validation were enabled by the close genetic relatedness to the 2003 SARS-CoV, and aided by the use of synthetic nucleic acid technology.”

Development of the bogus COVID-19 tests was funded by European Union DG Research through projects Prepare (GA602525), Compare (GA643476), and EVAg (GA653316); by European Union DG SANCO through EVD-LabNet, as well as by the German Ministry of Research through projects RAPID (01KI1723A) and DZIF (301-4-7-01.703).

Germany funded, developed and deployed these bogus COVID-19 test to make $billions. To intentionally misdiagnose a patient for financial gain is a criminal offence – health care fraud.

Germany’s COVID-19 mRNA vaccines contain the human herpes virus protein ORF10

Herpes test kit that can prove Germany added SARS-CoV-2’S unique human herpes virus protein ORF10 to its COVID-19 mRNA vaccines.

There is material evidence that supports the assertion that Germany’s mRNA vaccines are biological weapons – used by Germany to infect the World’s population with SARS-CoV-2’s unique human herpes virus protein ORF10.

On August 12, 2021 Europe’s drug regulator EMA published new updates on the safety of mRNA vaccines after it investigated a possible link between mRNA vaccines and a skin reaction called erythema multiforme. Erythema multiforme is a hypersensitivity reaction usually triggered by infections, most commonly herpes simplex virus (HSV).

The human herpes virus protein ORF10 is the only protein that is present exclusively in SARS-CoV-2 and not in SARS or any other human coronaviruses.

The WHO’s COVID-19 Global literature on coronavirus disease suggested the severity of COVID-19 is enhanced by the human herpes virus protein ORF10.

“Could the severity of COVID-19 be enhanced by ORF10 accessory proteins?” …

“uniqueness of ORF10 and predicted intrinsic characteristics support possible involvement of ORF10 protein in giving COVID-19 its specific characteristics like spread and virulence” the World Heath Organization

Since 1972 the WHO/UN has called for/recommended virologists develop the means to prolong virus/coronavirus infections. Bulletin of the World Health Organization, Volume 47, p.259, 1972, Recommendations (3):

An attempt should be made to see if viruses can in fact exert selective effects on immune function. e.g. by depressing (to diminish the activity, strength, or yield of) 7S (IgG) versus 19S (IgM) antibody, or by affecting T cell function as opposed to B cell function. The possibility should be looked into that the immune response to the virus itself may be impaired if the infecting virus damages, more or less selectively the cells responding to the viral antigens. If this proves to be the case, virus-induced immunodepression might conceivably be highly instrumental in prolonging certain virus infections, such as murine leukemia, hepatitis, …

Virologists did that by genetically engineering/modifying the SARS coronavirus. The human herpes virus protein ORF10 was encoded into the SARS coronavirus to make the novel coronavirus SARS-CoV-2.

A 2003 patent informs us when the herpes virus protein ORF10 was added to the SARS virus by virologists to create the novel coronavirus SARS-CoV-2. The 2003 Patent US-2006257852-A1 assigned to CHIRON CORP (US), which was acquired by Novartis (Switzerland) on April 20, 2006 specifically names the ORF10 protein – a protein that is exclusively found in SARS-CoV-2 genome and not in SARS-CoV, being used/encoded in the fusion protein of the patented novel SARS coronavirus.

2021 published study “SARS-CoV-2 ORF10 suppresses the antiviral innate immune response by degrading MAVS through mitophagy” informs you why Germany’s COVID-19 mRNA vaccine ingredients includes a bioengineered or synthesized component of SARS-CoV-2, the viral protein that causes COVID-19 – ORF10.

“ORF10 plays a vital role at all stages of SARS-CoV-2 infection. In our study, overexpression of ORF10 promoted the degradation of MAVS and the replication of SARS-CoV-2. Consistent with these results, when ORF10 was knocked down by shRNA, MAVS was not degraded and viral replication was weakened, suggesting that ORF10 facilitates SARS-CoV-2 replication via degradation of MAVS.” 

ORF10 was included because it facilities/causes new SARS-CoV-2 infections. Causing new SARS-CoV-2 infections generates more vaccine sales for Germany.

Related NCIO briefing:

Germany informed World that its COVID-19 mRNA vaccines are biological weapons